Skip to main content

Table 1 Clinical characteristics of patients in both study groups

From: The efficacy of laparoscopic uterosacral nerve ablation (LUNA) in the treatment of unexplained chronic pelvic pain: a randomized controlled trial

 

Group I (control) N = 85

Group II (study) N = 86

P value

Age (years)

Range

25–45

24–43

NS

(Mean ± SD)

31.90 ± 2.44

30.25 ± 2.55

Weight (kg)

Range

48–75

50–72

NS

(Mean ± SD)

66–11 ± 5.31

67.18 ± 4.34

Height (cm)

Range

153–170

152–173

NS

(Mean ± SD)

163 ± 1.17

161 ± 2.10

BMI (kg/m2)

Range

24.40–29.55

23.66–28.41

NS

(Mean ± SD)

24.80 ± 1.46

25.23 ± 1.25

Parity (N)

Range

1–8

1–7

NS

(Mean ± SD)

4.78 ± 1.65

5.43 ± 1.61

Clinical presentation(s), N (%)

   

 Acyclic lower abdominal pain

28 (32.9%)

25 (29%)

NS

 Congestive dysmenorrhea

38 (44.7%)

40 (46.5%)

NS

 Spasmodic dysmenorrhea

36 (42.3%)

35 (40.6%)

NS

 Deep dyspareunia

33 (38.8%)

30 (34.8%)

NS

Pervaginal findings, N (%)

   

 Pelvic tenderness

18/85 (21.1%)

19/86 (22.9%)

NS

  Localized to one fornix

6/18 (33.3%)

7/19 (36.8%)

NS

  Bilateral

3/18 (16.6%)

3/19 (15.7%)

NS

  Diffuse

9/18 (50%)

12/19 (63.3%)

NS

 Fornical fullness

14/85 (16.4%)

12/86 (13.9%)

NS

  Unilateral

5/14 (35.7%)

5/12 (41.6%)

NS

  Bilateral

9/14 (64.2%)

7/12 (85.3%)

NS

 Cul-de-sac nodularity

3/85 (3.5%)

2/86 (2.3)

NS

 Fixed retroverted uterus

1/85 (1.1%)

1/86 (1.1%)

NS

 No significant finding

16/85 (18.8%)

18/86 (20.9%)

NS

  1. NS not significant